# Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)

> **NCT06234436** · EARLY_PHASE1 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **BIOLOGICAL:** Plasma exchenge

## Key facts

- **NCT ID:** NCT06234436
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234436, "Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06234436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*